Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease
Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease
复制标题
DOI:
10.1161/01.cir.0000020009.30736.3f
复制
发表时间:
2002-07-02
期刊:
影响因子:
37.8
通讯作者:
Gatzoulis, MA
中科院分区:
文献类型:
--
作者:
Bolger, AP;Sharma, R;Gatzoulis, MA
Background-Neurohormonal activation characterizes chronic heart failure, relates to outcome, and is a therapeutic target. It is not known whether a similar pattern of neurohormonal activation exists in adults with congenital heart disease and, if so, whether it relates to common measures of disease severity or whether cardiac anatomy is a better discriminant.Methods and Results-Concentrations of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), endothelin-1 (ET-1), renin, aldosterone, norepinephrine, and epinephrine were determined in 53 adults with congenital heart disease, comprising 4 distinct anatomic subgroups (29 female: 33.5+/-1.5 years of age: New York Heart Association class 2.0+/-0.1, mean+/-SEM) aid 15 healthy control subjects (8 female 32,3 13 years of age), Systemic ventricular function was graded by a blinded echocardiographer as normal or mildly, moderately, or severely impared. Adults with congenital heart disease had elevated levels of ANP (56.6 versus 3.1 pmol/L). BNP (35.8 versus 5.7 pmol/L), ET-1 (2.5 versus 0.7 pmol/L, all P